Free shipping on all orders over $ 500

Empagliflozin

Cat. No. M2667

All AbMole products are for research use only, cannot be used for human consumption.

Empagliflozin  Structure
Synonym:

BI 10773

Size Price Availability Quantity
10mM*1mL in DMSO USD 45 In stock
5mg USD 40 In stock
10mg USD 55 In stock
100mg USD 95 In stock
200mg USD 120 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Empagliflozin (BI-10773) is a potent and selective SGLT-2 inhibitor with IC50 of 3.1 nM, exhibits >300-fold selectivity over SGLT-1, 4, 5 and 6.

Protocol (for reference only)
Cell Experiment
Cell lines HK-2 cells
Preparation method Cellular Apoptotic Assay
In the terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) assay, HK-2 cells incubated for 24 h in the presence or absence of empagliflozin were fixed in 4% paraformaldehyde and treated with a blocking solution (10% FBS in PBS) for 30 min at 25 °C. Cells were permeabilized with 0.1% (v/v) Triton X-100 in PBS, followed by incubation with the TUNEL reaction mixture for 1 h at 37 °C. After the treatment, the cells were observed under a fluorescence microscope.
Concentrations 100 and 500 nM
Incubation time 24 h
Animal Experiment
Animal models Male C57BL/6J mice (10 weeks of age)
Formulation dissolved in hydroxy ethyl cellulose (HEC)
Dosages 3 or 10 mg/kg
Administration oral gavage
Chemical Information
Molecular Weight 450.91
Formula C23H27ClO7
CAS Number 864070-44-0
Solubility (25°C) DMSO 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Wen-Chin Lee, et al. Cells. Empagliflozin Protects HK-2 Cells from High Glucose-Mediated Injuries via a Mitochondrial Mechanism

[2] Mizuno M, et al. Physiol Rep. Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts.

[3] Sam Tsz Wai Cheng, et al. PLoS One. The Effects of Empagliflozin, an SGLT2 Inhibitor, on Pancreatic β-Cell Mass and Glucose Homeostasis in Type 1 Diabetes

Related SGLT Products
Dapagliflozin

Dapagliflozin (BMS-512148) is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2).

Canagliflozin

Canagliflozin is a potent, selective sodium glucose co-transporter 2 inhibitor.

Phloridzin

Phloridzin is a non-selective SGLT inhibitor with Kis of 300 and 39 nM for hSGLT1 and hSGLT2, respectively. Phlorizin is also a Na+/K+-ATPase inhibitor.

Phloretin

Phloretin (NSC 407292; RJC 02792) is a specific, competitive and orally active inhibitor of sodium/glucose cotransporters in the intestine (SGLT1) and kidney (SGLT2).

Sotagliflozin

Sotagliflozin (LX-4211) is an orally active, first-in-class dual SGLT1/2 inhibitor with IC50s of 36 nM and 1.8 nM, respectively, and is used in studies related to type 1 diabetes and heart failure.

  Catalog
Abmole Inhibitor Catalog




Keywords: Empagliflozin , BI 10773 supplier, SGLT, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.